8.54
Precedente Chiudi:
$8.55
Aprire:
$8.55
Volume 24 ore:
755.34K
Relative Volume:
0.20
Capitalizzazione di mercato:
$354.50M
Reddito:
$324.00K
Utile/perdita netta:
$-82.10M
Rapporto P/E:
-9.1828
EPS:
-0.93
Flusso di cassa netto:
$-69.18M
1 W Prestazione:
+0.00%
1M Prestazione:
+0.00%
6M Prestazione:
+80.17%
1 anno Prestazione:
+769.12%
Chimerix Inc Stock (CMRX) Company Profile
Nome
Chimerix Inc
Settore
Industria
Telefono
919.806.1074
Indirizzo
2505 MERIDIAN PARKWAY, SUITE 100, DURHAM, NC
Confronta CMRX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
CMRX
Chimerix Inc
|
8.54 | 354.50M | 324.00K | -82.10M | -69.18M | -0.93 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Chimerix Inc Stock (CMRX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-05-23 | Iniziato | Robert W. Baird | Outperform |
2022-09-07 | Iniziato | CapitalOne | Overweight |
2021-04-29 | Iniziato | Maxim Group | Buy |
2021-04-23 | Ripresa | Cowen | Outperform |
2021-03-31 | Iniziato | Jefferies | Buy |
2021-03-31 | Iniziato | Wedbush | Outperform |
2018-02-14 | Downgrade | JP Morgan | Neutral → Underweight |
2018-02-02 | Iniziato | H.C. Wainwright | Buy |
2016-08-09 | Reiterato | FBR Capital | Mkt Perform |
2016-02-23 | Downgrade | Barclays | Overweight → Equal Weight |
2016-02-23 | Reiterato | FBR Capital | Mkt Perform |
2016-02-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
2016-02-22 | Downgrade | Citigroup | Buy → Neutral |
2015-12-29 | Downgrade | JP Morgan | Overweight → Neutral |
2015-12-28 | Downgrade | FBR Capital | Outperform → Mkt Perform |
2015-12-28 | Reiterato | Piper Jaffray | Overweight |
2015-12-17 | Iniziato | UBS | Buy |
2015-10-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2015-09-03 | Iniziato | Citigroup | Buy |
2015-08-18 | Iniziato | FBR Capital | Outperform |
2015-08-06 | Reiterato | Brean Capital | Buy |
2015-05-11 | Reiterato | Brean Capital | Buy |
2015-03-04 | Iniziato | Barclays | Overweight |
2015-02-12 | Reiterato | Stifel | Buy |
2014-12-31 | Reiterato | Brean Capital | Buy |
2014-07-08 | Ripresa | Brean Capital | Buy |
Mostra tutto
Chimerix Inc Borsa (CMRX) Ultime notizie
Former Chimerix CEO Andriole to lead Artios - biocentury.com
Jazz gets FDA okay for Chimerix brain cancer drug - pharmaphorum
Jazz Earnings: Xywav and Epidiolex Drive Growth; US Approval for Chimerix's Dordaviprone Promising - Morningstar
Chimerix buyout a win for Jazz with FDA nod for rare glioma drug - BioWorld MedTech
FDA approves targeted brain cancer drug from Jazz’s Chimerix buyout - Endpoints News
JAZZ Stock Down on Wider-Than-Expected Q2 Loss, '25 Sales View Cut - TradingView
Jazz Pharmaceuticals 2025 Q2 Earnings Misses Targets as Net Loss Surges 538% - AInvest
Chimerix’s ONC201 Study: A Potential Game-Changer in Glioma Treatment - TipRanks
Comparing BetterLife Pharma (OTCMKTS:PVOTF) & Chimerix (NASDAQ:CMRX) - Defense World
Chimerix, Inc. (NASDAQ:CMRX) Shares Purchased by Two Sigma Investments LP - Defense World
Squarepoint Ops LLC Makes New Investment in Chimerix, Inc. (NASDAQ:CMRX) - Defense World
Jane Street Group LLC Buys New Position in Chimerix, Inc. (NASDAQ:CMRX) - Defense World
Two Sigma Advisers LP Has $41,000 Stock Holdings in Chimerix, Inc. (NASDAQ:CMRX) - Defense World
CHIMERIX Earnings Preview: Recent $CMRX Insider Trading, Hedge Fund Activity, and More - Nasdaq
Northern Trust Corp Sells 36,038 Shares of Chimerix, Inc. (NASDAQ:CMRX) - Defense World
Chimerix, Inc. (NASDAQ:CMRX) Shares Purchased by Millennium Management LLC - Defense World
Balyasny Asset Management L.P. Purchases Shares of 60,317 Chimerix, Inc. (NASDAQ:CMRX) - Defense World
Chimerix (NASDAQ:CMRX) Now Covered by StockNews.com - Defense World
StockNews.com Initiates Coverage on Chimerix (NASDAQ:CMRX) - Defense World
Halper Sadeh LLP, bluebird bio, Inc., Walgreens Boots Alliance, Chimerix, Inc. - Olean Times Herald
Chimerix (NASDAQ:CMRX) Earns Sell Rating from Analysts at StockNews.com - Defense World
Chimerix, Inc. to Host Earnings Call - ACCESS Newswire
Why Chimerix Inc. (CMRX) is Surging in 2025 - Insider Monkey
Investor Network: Chimerix, Inc. to Host Earnings Call - ACCESS Newswire
Geode Capital Management LLC Lowers Stock Holdings in Chimerix, Inc. (NASDAQ:CMRX) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Jazz Pharmaceuticals Acquires Chimerix for $935M - Contract Pharma
Jazz Pharmaceuticals Completes $935 Million Acquisition of Chimerix - marketscreener.com
Jazz Pharmaceuticals acquires Chimerix for $935 million By Investing.com - Investing.com South Africa
Chimerix Terminates Loan and Delists from Nasdaq - TipRanks
Jazz Pharmaceuticals Completes Acquisition of Chimerix | JAZZ St - GuruFocus
Jazz Pharmaceuticals (JAZZ) Completes Acquisition of Chimerix - StreetInsider
Jazz Pharmaceuticals Completes Acquisition of Chimerix - TipRanks
Jazz Pharmaceuticals acquires Chimerix for $935 million - Investing.com
Jazz Pharmaceuticals Completes Acquisition of Chimerix | JAZZ Stock News - GuruFocus
Jazz's $935M Chimerix Buyout Targets First-Ever Treatment for Rare Brain Cancer, FDA Verdict Looms - Stock Titan
Jazz Pharmaceuticals' $935M Chimerix Deal: A Bold Move in Rare Oncology - AInvest
Chimerix stock soars to 52-week high, hits $8.54 By Investing.com - Investing.com South Africa
Chimerix stock soars to 52-week high, hits $8.54 - Investing.com
Unlocking Investment Potential Discover the Power of Magical Signals Bullish Signal - AInvest
Top 3 Health Care Stocks That May Crash In Q2 - Benzinga
Chimerix stock soars to 52-week high, hits $8.53 By Investing.com - Investing.com Australia
Chimerix stock soars to 52-week high, hits $8.53 - Investing.com
Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025? - MSN
Jazz Pharmaceuticals, Chimerix HSR waiting period expired on March 31 - MLex
11 Best Performing NASDAQ Stocks So Far in 2025 - Insider Monkey
Exploring US High Growth Tech Stocks In March 2025 - simplywall.st
Chimerix Inc Azioni (CMRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):